Indication

Ranibizumab

1 clinical trial

1 product

Clinical trial

Intravitreal Ranibizumab Injection In Aggressive Retinopathy Of Prematurity Compared With Type 1 Prethreshold Retinopathy Of Prematurity

Status: Completed, Estimated PCD: 2022-11-20

Product